Advertisement
Screener

NPS PHARMACEUTICALS INC Operating Expenses

NPS PHARMACEUTICALS INC Operating Expenses

NPS PHARMACEUTICALS INC reported Operating Expenses of $204.36 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-18.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2015-02-18

  • NPS PHARMACEUTICALS INC operating expenses for the quarter ending 2014-12-31 was $58.98M, a 40.83% increase year-over-year.
  • NPS PHARMACEUTICALS INC operating expenses for the quarter ending 2014-09-30 was $52.67M, a 44.87% increase year-over-year.
  • NPS PHARMACEUTICALS INC operating expenses for the quarter ending 2014-06-30 was $47.60M, a 4.95% increase year-over-year.
  • NPS PHARMACEUTICALS INC operating expenses for the quarter ending 2014-03-31 was $45.11M, a 50.87% increase year-over-year.
  • NPS PHARMACEUTICALS INC operating expenses for fiscal 2014 was $204.36M, a 33.14% increase from fiscal 2013.
  • NPS PHARMACEUTICALS INC operating expenses for fiscal 2013 was $153.49M, a 16.49% increase from fiscal 2012.
  • NPS PHARMACEUTICALS INC operating expenses for fiscal 2012 was $131.77M, a 34.38% increase from fiscal 2011.
  • NPS PHARMACEUTICALS INC operating expenses for fiscal 2011 was $98.06M, a 22.82% increase from fiscal 2010.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 9 month as first filedOperating Expenses 12 monthOperating Expenses 12 month as first filed
2014-12-31$58.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18
$111.65M
derived: sum of 2 quarters · filed 2015-02-18
$159.25M
derived: sum of 3 quarters · filed 2015-02-18
$204.36M
10-K · filed 2015-02-18
2014-09-30$52.67M
10-Q · filed 2014-11-10
$100.27M
derived: sum of 2 quarters · filed 2014-11-10
$145.38M
10-Q · filed 2014-11-10
$187.26M
derived: sum of 4 quarters · filed 2015-02-18
2014-06-30$47.60M
10-Q · filed 2014-08-06
$92.71M
10-Q · filed 2014-08-06
$134.59M
derived: sum of 3 quarters · filed 2015-02-18
$170.95M
derived: sum of 4 quarters · filed 2015-02-18
2014-03-31$45.11M
10-Q · filed 2014-05-08
$86.99M
derived: sum of 2 quarters · filed 2015-02-18
$123.35M
derived: sum of 3 quarters · filed 2015-02-18
$168.70M
derived: sum of 4 quarters · filed 2015-02-18
2013-12-31$41.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18
$78.24M
derived: sum of 2 quarters · filed 2015-02-18
$123.59M
derived: sum of 3 quarters · filed 2015-02-18
$153.49M
10-K · filed 2015-02-18
2013-09-30$36.36M
10-Q · filed 2014-11-10
$37.43M
10-Q · filed 2013-11-06
$81.71M
derived: sum of 2 quarters · filed 2014-11-10
$111.61M
10-Q · filed 2014-11-10
$113.22M
10-Q · filed 2013-11-06
$146.81M
derived: sum of 4 quarters · filed 2015-02-18
2013-06-30$45.35M
10-Q · filed 2014-08-06
$45.83M
10-Q · filed 2013-08-08
$75.25M
10-Q · filed 2014-08-06
$75.79M
10-Q · filed 2013-08-08
$110.45M
derived: sum of 3 quarters · filed 2015-02-18
$136.74M
derived: sum of 4 quarters · filed 2015-02-18
2013-03-31$29.90M
10-Q · filed 2014-05-08
$29.96M
10-Q · filed 2013-05-09
$65.10M
derived: sum of 2 quarters · filed 2015-02-18
$91.39M
derived: sum of 3 quarters · filed 2015-02-18
$133.70M
derived: sum of 4 quarters · filed 2015-02-18
2012-12-31$35.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18
$61.49M
derived: sum of 2 quarters · filed 2015-02-18
$103.80M
derived: sum of 3 quarters · filed 2015-02-18
$131.77M
10-K · filed 2015-02-18
2012-09-30$26.29M
10-Q · filed 2013-11-06
$68.60M
derived: sum of 2 quarters · filed 2013-11-06
$96.57M
10-Q · filed 2013-11-06
$122.29M
derived: sum of 4 quarters · filed 2014-02-18
2012-06-30$42.31M
10-Q · filed 2013-08-08
$70.28M
10-Q · filed 2013-08-08
$96.00M
derived: sum of 3 quarters · filed 2014-02-18
$122.64M
derived: sum of 4 quarters · filed 2014-02-18
2012-03-31$27.97M
10-Q · filed 2013-05-09
$53.69M
derived: sum of 2 quarters · filed 2014-02-18
$80.33M
derived: sum of 3 quarters · filed 2014-02-18
$103.51M
derived: sum of 4 quarters · filed 2014-02-18
2011-12-31$25.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18
$52.36M
derived: sum of 2 quarters · filed 2014-02-18
$75.54M
derived: sum of 3 quarters · filed 2014-02-18
$98.06M
10-K · filed 2014-02-18
$101.10M
10-K · filed 2012-02-15
2011-09-30$26.64M
10-Q · filed 2012-11-09
$49.82M
derived: sum of 2 quarters · filed 2012-11-09
$72.33M
10-Q · filed 2012-11-09
$93.59M
derived: sum of 4 quarters · filed 2013-02-21
2011-06-30$23.17M
10-Q · filed 2012-08-01
$45.69M
10-Q · filed 2012-08-01
$66.95M
derived: sum of 3 quarters · filed 2013-02-21
$91.73M
derived: sum of 4 quarters · filed 2013-02-21
2011-03-31$22.52M
10-Q · filed 2012-05-03
$43.77M
derived: sum of 2 quarters · filed 2013-02-21
$68.56M
derived: sum of 3 quarters · filed 2013-02-21
$88.55M
derived: sum of 4 quarters · filed 2013-02-21
2010-12-31$21.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21
$46.04M
derived: sum of 2 quarters · filed 2013-02-21
$66.03M
derived: sum of 3 quarters · filed 2013-02-21
$79.84M
10-K · filed 2013-02-21
2010-09-30$24.78M
10-Q · filed 2011-11-03
$44.77M
derived: sum of 2 quarters · filed 2011-11-03
$58.58M
10-Q · filed 2011-11-03
2010-06-30$19.99M
10-Q · filed 2011-08-02
$33.80M
10-Q · filed 2011-08-02
2009-12-31$56.45M
10-K · filed 2012-02-15